Meyka Pro banner
High Tide Inc.

High Tide Inc. (NASDAQ: HITI) Stock Competitors & Peer Comparison

See HITI's competitors and their performance on the NASDAQ and across the wider stock market.

HITINASDAQ
HealthcareMedical - Pharmaceuticals
$2.51
$0.00(0.00%)
U.S. Market opens in 11h 4m

Peer Comparison Table: Medical - Pharmaceuticals Industry

Detailed financial metrics including price, market cap, P/E ratio, and more for HITI and its NASDAQ peers.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
HITI$2.51-2.33%220.6M-7.36-$0.34N/A
RPRX$60.85-1.73%27B11.59$5.25+1.52%
CORT$113.88-2.61%12.3B325.37$0.35N/A
WBA$11.98+0.50%10.4B-1.64-$7.29+4.17%
KNSA$78.08-0.76%6.1B88.67$0.90N/A
LQDA$67.69-3.22%6B483.50$0.14N/A
PBH$52.47+2.46%2.5B11.87$4.42N/A
LTGO$24.23-3.08%1.5BN/AN/AN/A
HROWL$25.61+0.19%1.4BN/AN/AN/A
HROWM$26.03-0.08%1.3BN/AN/AN/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

Royalty Pharma plc (NASDAQ: RPRX)

HITI vs RPRX Comparison September 2026

High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HITI stands at 220.6M. In comparison, RPRX has a market cap of 27B. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while RPRX trades at $60.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HITI currently has a P/E ratio of -7.36, whereas RPRX's P/E ratio is 11.59. In terms of profitability, HITI's ROE is -0.43%, compared to RPRX's ROE of +0.12%. Regarding short-term risk, HITI is more volatile compared to RPRX. This indicates higher risk in terms of short-term price fluctuations for HITI.Check RPRX's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions